Catch-Up Vaccines

BCG Vaccine

  • Catch up vaccination: may be given up to 5years

Hepatitis B (HepB) Vaccine

  • Administer the 3-dose series to those not previously vaccinated.
  • In catch up vaccination use 0, 1, and 6 months schedule.

Poliovirus Vaccines

  • IPV catch-up schedule: 2 doses at 2 months apart followed by a booster after 6 months of previous dose.

Diphtheria and Tetanus Toxoids and Pertussis (DTP) Vaccine

  • Catch-up Schedule: The 2nd childhood booster is not required if the last dose has been given beyond the age of 4 years.
  • Catch-up below 7 years: DTwP/DTaP at 0, 1 and 6 months.
  • Catch up above 7 years: Tdap, Td, and Td at 0, 1 and 6 months.

Tetanus and Diphtheria Toxoids and Acellular Pertussis (Tdap) Vaccine

  • Catch-Up above 7 years: Tdap, Td, Td at 0, 1 and 6 months.
  • Persons aged 7 through 10 years who are not fully immunized with the childhood DTwP/DTaP vaccine series, should receive Tdap vaccine as the first dose in the catch-up series; if additional doses are needed, use Td vaccine. For these children, an adolescent Tdap vaccine should not be given.
  • Persons aged 11 through 18 years who have not received Tdap vaccine should receive a dose followed by tetanus and diphtheria toxoids (Td) booster doses every 10 years thereafter.
  • Tdap vaccine can be administered regardless of the interval since the last tetanus and diphtheria toxoid containing vaccine.

Haemophilus Influenza Type B (Hib) Conjugate Vaccine

  • Catch-up is recommended till 5 years of age.
  • 6-12 months: 2 primary doses 4 weeks apart and 1 booster.
  • 12-15 months: 1 primary dose and 1 booster.
  • Above 15 months: single dose.
  • If the first dose was administered at age 7 through 11 months, administer the second dose atleast 4 weeks later and a final dose at age 12-18 months atleast 8 weeks after the second dose.

Pneumococcal Conjugate Vaccines (PCVs) Routine Vaccination

  • Catch-up vaccination: Administer 1 dose of PCV13 or PCV10 to all healthy children aged 24 through 59 months who are not completely vaccinated for their age.
  • For PCV 13: At 6-12 months, 2 doses 4 weeks apart and 1 booster. For 12-23 months, 2 doses 8 weeks apart. For 24 months and above, single dose.
  • For PCV10: For 6-12 months, 2 doses 4 weeks apart and 1 booster. For 12 months to 5 years, 2 doses 8 weeks apart.

Vaccination of persons with high-risk conditions:

  • PCV and Pneumococcal Polysaccharide Vaccine (PPSV) both are used in certain high risk group of children.
  • For children aged 24 through 71 months with certain underlying medical conditions, administer 1 dose of PCV13 if 3 doses of PCV were received previously, or administer 2 doses of PCV13 at least 8 weeks apart if fewer than 3 doses of PCV were received previously.
  • A single dose of PCV13 may be administered to previously un-vaccinated children aged 6 through 18 years who have anatomic or functional asplenia (including sickle cell disease), HIV infection or an immune-compromising condition, cochlear implant or cerebrospinal fluid leak.
  • Administer PPSV23 at least 8 weeks after the last dose of PCV to children aged 2 years or older with certain underlying medical conditions.

Rotavirus (RV) Vaccines

  • The maximum age for the first dose in the Series is 14 weeks, 6 days.
  • Vaccination should not be initiated for infants aged 15 weeks, 0 days or older.
  • The maximum age for the final dose in the series is 8 months, 0 days.

Measles, Mumps, and Rubella (MMR) Vaccine

  • Ensure that all school-aged children and adolescents have had 2 doses of MMR vaccine; the minimum interval between the 2 doses is 4 weeks.
  • One dose if previously vaccinated with one dose.
  • "Stand alone" measles/measles containing vaccine can be administered to infants aged 6 through 8 months during outbreaks. However, this dose should not be counted.

Varicella (Chickenpox) Vaccine

  • Ensure that all persons aged 7 through 18 years without "evidence of immunity" have 2 doses of the vaccine.
  • For children aged 12 months through 12 years, the recommended minimum interval between doses is 3 months. However, if the second dose was administered at least 4 weeks after the first dose, it can be accepted as valid.
  • For persons aged 13 years and older, the minimum interval between doses is 4 weeks.
  • For persons without evidence of immunity, administer 2 doses if not previously vaccinated or the second dose if only 1 dose has been administered.

"Evidence of immunity" to varicella includes any of the following:

  • Documentation of age-appropriate vaccination with a varicella vaccine.
  • Laboratory evidence of immunity or laboratory confirmation of disease.
  • Diagnosis or verification of a history of varicella disease by a health-care provider.
  • Diagnosis or verification of a history of herpes zoster by a health-care provider.

Hepatitis A (HepA) Vaccines

  • Either of the two vaccines can be used in "catch-up" schedule beyond 2 years of age.
  • Administer 2 doses for killed vaccine at least 6 months apart to unvaccinated persons.
  • Only single dose of live attenuated H2-strain vaccine.
  • For catch up vaccination, pre vaccination screening for Hepatitis A antibody is recommended in children older than 10 years as at this age the estimated seropositive rates exceed 50%.

Typhoid Vaccines

  • Recommended throughout the adolescent period, i.e. 18 years.

Human Papillomavirus (HPV) Vaccines

  • Administer the vaccine series to females (either HPV2 or HPV4) at age 13 through 45 years if not previously vaccinated.
  • Use recommended routine dosage intervals (see above) for vaccine series catch-up.

Meningococcal Vaccine

  • Particularly in children ≤ 2 years of age.